Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.
about
Development of minimally invasive techniques for management of medically-complicated obesityContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerNoninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound TechniqueTreating Obesity and Metabolic Syndrome with Fecal Microbiota TransplantationThe respiratory microbiome: an underappreciated player in the human response to inhaled pollutants?Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Daily Eating Patterns and Their Impact on Health and Disease.Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus.Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.Surgical treatment of nonalcoholic fatty liver disease in severely obese patientsDiet and feeding pattern affect the diurnal dynamics of the gut microbiomeBacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes.Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver diseaseEffect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis.Insulin regulates retinol dehydrogenase expression and all-trans-retinoic acid biosynthesis through FoxO1.Bariatric surgery: prevalence, predictors, and mechanisms of diabetes remission.Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.Exenatide extended-release; clinical trials, patient preference, and economic considerations.Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.Non-alcoholic fatty liver disease and diabetes.Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.TGR5, Not Only a Metabolic Regulator.Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions.Novel therapeutic targets for nonalcoholic fatty liver disease.The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders.The role of bariatric surgery in the treatment of type 2 diabetes: current evidence and clinical guidelines.Is there any interplay between incretins and bile acids? What is the role of bariatric surgery?The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.Liver sinusoid on a chip: Long-term layered co-culture of primary rat hepatocytes and endothelial cells in microfluidic platforms.Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study.Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study.Clues to arsenic's toxicity: microbiome alterations in the mouse gutI148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
P2860
Q26851369-DD202037-7C2B-4625-BE4A-F3ED782F15A2Q26992106-5EBB03D5-0C7C-4EDF-91A1-B8295B4AE263Q27318751-ED39CB40-45EA-491A-B04D-0554ED9765AEQ28078234-957F4330-4331-4279-B74D-7784CE02930FQ28396321-137885F2-C0BC-4340-A1E1-ABF615BB9D89Q30366569-001D99B9-3CE5-447F-8A58-10BC0536A143Q30382172-60E4AE2A-7D78-4945-ABAA-6885EF5F00A2Q30382902-E34F45F7-0882-4EE6-BED1-7593404826F7Q30413592-B615E398-3254-42B2-87D1-6B55D603FC35Q30418856-CE3E56CC-585E-498E-A247-3E52937749F6Q30870794-050537AC-D4C7-4AED-8A82-0383E84ACCE0Q33802278-98B7F575-7A29-43BA-B7D4-5F63C34AA3F2Q34425909-68A32143-FA50-4530-8ABA-097B4EA59CFDQ34446294-4900DE02-4555-4962-88CD-0211580967B8Q34628516-17A37843-8EB0-481D-B856-0E9FFB89ACE8Q34724632-07F55592-1266-47B7-B404-A72FD0F88190Q35039525-06181CAA-65DF-4FB5-94A4-5E2492AC62F8Q35096971-7A87FE1B-AF61-4C5C-B0C9-58A5492EA206Q35172702-FCEE4F66-0612-4C2A-B375-A757D1E55622Q35564937-80CE97C7-CB87-4578-9DA4-ADC4FA4F2F7EQ35769495-EC6A9A11-D975-4D58-8F8E-9D9549A46F0DQ36538817-9BB631B5-F7D9-4FE8-8083-59DA073C4FAFQ36569181-682BAADC-2C09-49A6-BDF4-696E6E57F152Q37091659-B71E7023-1AC7-48C0-9B84-F54445C82F7CQ37384502-8513BA9A-7849-43CB-A53B-6F7A8BFA188CQ37531608-ADB607EC-3813-4C2E-BC2E-1EC4FA49E155Q37721986-051E6997-AC97-47E3-AACC-E2342288B016Q38100206-89F0AFA9-2F51-44D0-93CA-00082168E98BQ38115636-77244E89-3BCE-4328-8BDF-0699FD03205AQ38146960-5328A439-7FD1-4DDD-BB85-66AC3F1DE6E1Q38623207-40952B3F-477A-440C-BA1F-B1E9EED15FE0Q38656970-AB69F2AB-64AC-46EF-8546-AC7BA214C2DFQ38820260-F9CF1D2D-E966-4C24-9B67-F468EAFCFD3AQ39262148-B398A729-BA58-4A4A-A447-5C4E6709D298Q40695544-ED04DBB6-3C6B-4C7E-8DE9-276048C3E6B5Q41212888-E6CA6652-620C-474C-AC34-A31A5EFA2738Q41605338-6067799A-AC0F-4222-83F5-599048D313A2Q42150413-6DD28B74-0622-4248-8D9E-C72C5CF52230Q42415979-006F5264-7C33-45C5-A851-7C7DF0E9A446Q50241143-F2A840A2-C410-49BA-B579-45ABA61CBCFA
P2860
Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Review article: the emerging i ...... alcoholic fatty liver disease.
@ast
Review article: the emerging i ...... alcoholic fatty liver disease.
@en
type
label
Review article: the emerging i ...... alcoholic fatty liver disease.
@ast
Review article: the emerging i ...... alcoholic fatty liver disease.
@en
prefLabel
Review article: the emerging i ...... alcoholic fatty liver disease.
@ast
Review article: the emerging i ...... alcoholic fatty liver disease.
@en
P2860
P356
P1476
Review article: the emerging i ...... alcoholic fatty liver disease.
@en
P2093
P2860
P304
P356
10.1111/APT.12084
P407
P577
2012-10-11T00:00:00Z